Related Experiment Video

Updated: Dec 22, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.6K

Specialist paediatric palliative care for children and young people with cancer: A mixed-methods systematic review

Johanna Taylor1,2, Alison Booth1,2, Bryony Beresford2,3

  • 1Department of Health Sciences, University of York, York, UK.

Palliative Medicine
|May 5, 2020
PubMed

Insights

Specialist pediatric palliative care for children with cancer is linked to different end-of-life care, but its impact on quality of life remains unclear. Access barriers exist, and further research is needed.

Area of Science:

  • Pediatric Oncology
  • Palliative Care Research
  • Health Services Research

Background:

  • Specialist pediatric palliative care (SPPC) is promoted for children with cancer.
  • Uncertainty exists regarding the specific role and impact of SPPC for this population.

Purpose of the Study:

  • To evaluate the impact of SPPC on children and young people with cancer.
  • To identify factors influencing access to SPPC for pediatric cancer patients.

Main Methods:

  • A mixed-methods systematic review and narrative synthesis.
  • Searches of multiple databases (2000-2019) identified 42 primary studies of any design.
  • Study quality was assessed using The Mixed Methods Appraisal Tool.

Main Results:

  • SPPC is associated with less intensive end-of-life care, more advance care planning, and fewer in-hospital deaths.
  • Evidence is insufficient to determine if SPPC improves symptom burden or quality of life.
  • Barriers to access include uncertainty about services, concerns about new teams, and timing of introduction; children with hematological malignancies access SPPC less.

Conclusions:

  • Children with cancer receiving SPPC experience different care patterns.
  • Further research is needed to understand patient perspectives and confirm if SPPC improves quality of life.
Abstract

Keywords:
Palliative careadolescentchildhospice careneoplasmssystematic reviewterminal care

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

51.7K

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
584
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
148
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
170
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
130